GL1X · GenesisL1 explorer

MolNFT v1 · #191337 · protein

CEREBLON~DDB1 in the apo form with DDB1 in the hinged conformation

8D7X · DNA damage-binding protein 1: “CEREBLON~DDB1 in the apo form with DDB1 in the hinged conformation”. Electron microscopy, 1 ligand (ZN), 20 pockets (best druggability 0.85). MolNFT v1 #191337 on GenesisL1: 3D structure, binding sites…

PDB
8D7X
Type
protein
Length
1,484 residues
Chains
2
Method
electron microscopy
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
DNA damage-binding protein 1; Protein cereblon
UniProt
Q16531, Q96SW2
Ligands
ZN
Pockets
20 · best druggability 0.85

Structure

electron microscopy · 2 distinct chains · 10% helix, 40% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ADNA damage-binding protein 1protein11355% helix, 44% strandQ16531
BProtein cereblonprotein34926% helix, 30% strandQ96SW2

Ligands and binding sites

  • ZN · Zinc ion · metal · chains B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

20 pockets found on a 1 Å grid, 14 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
111080.850.8692empty
211660.810.83152empty
311270.810.82106empty
42920.740.8760empty
53850.710.8362empty

Interfaces

1 interface between chains.

  • A–B · 2376 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 8D7X · Cereblon~DDB1 in the Apo form with DDB1 in the hinged conformation · the same entry in another collection · chain A against A, TM-score 1.00
  • Q16531 · AlphaFold monomer V2.0 prediction for DNA damage-binding protein 1 (Q16531) · a predicted model of the same protein · chain A against A, TM-score 0.87
  • Q96SW2 · AlphaFold monomer V2.0 prediction for protein cereblon (Q96SW2) · a predicted model of the same protein · chain B against A, TM-score 0.75

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.